Your browser doesn't support javascript.
loading
Advanced tube formation assay using human endothelial colony forming cells for in vitro evaluation of angiogenesis.
Lee, Hyunsook; Kang, Kyu-Tae.
Afiliação
  • Lee H; College of Pharmacy, Duksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Korea.
  • Kang KT; College of Pharmacy, Duksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Korea.
Korean J Physiol Pharmacol ; 22(6): 705-712, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30402031
ABSTRACT
The tube formation assay is a widely used in vitro experiment model to evaluate angiogenic properties by measuring the formation of tubular structures from vascular endothelial cells (ECs). in vitro experimental results are crucial when considered the advisability of moving forward to in vivo studies. Thus, the additional attentions to the in vitro assay is necessary to improve the quality of the pre-clinical data, leading to better decision-making for successful drug discovery. In this study, we improved the tube formation assay system in three aspects. First, we used human endothelial colony forming cells (ECFCs), which are endothelial precursors that have a robust proliferative capacity and more defined angiogenic characteristics compared to mature ECs. Second, we utilized a real-time cell recorder to track the progression of tube formation for 48 hours. Third, to minimize analysis error due to the limited observation area, we used image-stitching software to increase the microscope field of view to a 2×2 stitched area from the 4× object lens. Our advanced tube formation assay system successfully demonstrated the time-dependent dynamic progression of tube formation in the presence and absence of VEGF and FGF-2. Vatalanib, VEGF inhibitor, was tested by our assay system. Of note, IC50 values of vatalanib was different at each observation time point. Collectively, these results indicate that our advanced tube formation assay system replicates the dynamic progression of tube formation in response to angiogenic modulators. Therefore, this new system provides a sensitive and versatile assay model for evaluating pro- or anti-angiogenic drugs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Korean J Physiol Pharmacol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Korean J Physiol Pharmacol Ano de publicação: 2018 Tipo de documento: Article